Lv2
122 积分 2024-09-14 加入
Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases
2天前
已完结
Thirty years of NRF2: advances and therapeutic challenges
1个月前
已完结
Thirty years of NRF2: advances and therapeutic challenges
1个月前
已完结
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes
2个月前
已完结
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
2个月前
已完结
Heart Disease and Relaxin: New Actions for an Old Hormone
2个月前
已完结
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
2个月前
已完结
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
3个月前
已完结
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases
3个月前
已完结
Prospects for PARG inhibitors in cancer therapy
3个月前
已完结
皖公网安备34019202002308
